Testosterone Enanthate vs Cypionate: What Actually Differs

Testosterone enanthate and cypionate are close to interchangeable on paper: both FDA labels give the same dose range, and the AUA guideline lists them with identical dosing and monitoring. Online claims that one is stronger, safer, or much longer-lasting don't hold up. The real differences are the oil each one comes in and how much measured data exists on its timing.

Both are testosterone with an ester (a fatty-acid side chain) attached. The ester changes how long one injection lasts. The cypionate label warns against swapping cypionate for testosterone propionate "because of differences in duration of action" (DEPO-Testosterone label). Enanthate carries a heptanoyl (seven-carbon) ester, and cypionate a cyclopentylpropionate ester (testosterone enanthate label).

How long does each one last?

Cypionate's half-life after an intramuscular injection is about 8 days, according to its FDA label (DEPO-Testosterone label). A half-life is the time it takes for the level to fall by half, so levels drift down between shots instead of dropping all at once.

The enanthate label gives no half-life for the ester. It only notes that testosterone itself, once released, has a half-life of 10 to 100 minutes (testosterone enanthate label). The enanthate half-lives quoted online vary widely, from about 4 to 10 days, and none of them comes from an FDA label.

What exists for both is measured blood levels after injection:

• Cypionate: in 11 men given 200 mg intramuscularly, average testosterone peaked at 1,112 ng/dL on days 4 to 5 and fell to about 400 ng/dL by day 14 (Shoskes et al., Transl Androl Urol 2016).
• Enanthate: in 23 men with primary hypogonadism, 100 mg weekly peaked above 1,200 ng/dL at 24 hours and was a little above 600 ng/dL a week later. At 200 mg every 2 weeks, the peak came at 48 hours and levels reached the low end of normal by week 2 (Shoskes et al., 2016, summarizing Snyder and Lawrence, JCEM 1980).

These are separate small studies with different doses and designs, so they can't settle which ester lasts longer. No fetched head-to-head trial in men answers that.

Why do levels rise and fall between shots?

With either ester, levels climb above the normal range in the first days after a shot and then fall through the interval. The Shoskes review notes that these swings "can result in mood swings or changes in libido" (Shoskes et al., 2016).

Dosing schedule changes the curve within one ester. Snyder and Lawrence compared enanthate at 100 mg weekly, 200 mg every 2 weeks, 300 mg every 3 weeks, and 400 mg every 4 weeks. All four kept levels mostly in the normal range, and the average level between doses was highest at 100 mg weekly and lowest at 400 mg every 4 weeks (Snyder and Lawrence, 1980). No trial has compared the two esters at the same schedule.

Enanthate has also been tested under the skin. In a phase II study of 39 men, weekly subcutaneous enanthate from an autoinjector gave normal levels "with low variation relative to 200-mg IM" (Kaminetsky et al., Sex Med 2015). The intramuscular vs subcutaneous injection guide covers that choice.

Is one stronger or safer?

Neither label supports that. Both list the same replacement dose for men with hypogonadism, 50 to 400 mg every 2 to 4 weeks (DEPO-Testosterone label; testosterone enanthate label). The AUA's dosing table gives both the same starting dose of 100 mg, a range of 50 to 200 mg every 7 to 14 days, and a testosterone check "after cycle 4" (AUA Table 2, 2018). These are label and guideline ranges. Your own dose is set by the prescriber from your labs and symptoms.

On safety, the Shoskes review says enanthate's side effects "mimic those of TC" (cypionate). Both labels carry the same blood pressure warning and both call for periodic hemoglobin and hematocrit checks.

What is actually different?

The oil and preservative. Cypionate (DEPO-Testosterone) comes in cottonseed oil with benzyl benzoate, preserved with benzyl alcohol (DEPO-Testosterone label). Generic enanthate comes in sesame oil, preserved with chlorobutanol (testosterone enanthate label). If you have reacted to one product, or have a known allergy to one of these ingredients, tell your prescriber; the ingredient lists differ.

The labeled uses also differ slightly. The enanthate label adds delayed puberty in selected boys and a secondary use in some postmenopausal women with metastatic breast cancer (testosterone enanthate label). For adult men with low testosterone, both are replacement therapy.

Beyond that, the choice often comes down to which one the pharmacy stocks and which one you have already done well on.

Side effects

The side effects come from testosterone, not the ester. The cypionate label lists acne, seborrhea (oily skin), male pattern baldness, increased or decreased libido, anxiety, depression, fluid retention, venous blood clots, and gynecomastia (breast tissue growth) that "occasionally persists." It also warns that "oligospermia may occur after prolonged administration or excessive dosage" (DEPO-Testosterone label). Oligospermia means a low sperm count. These older labels list side effects without rates.

Testosterone can raise hematocrit (the share of your blood made of red cells). The AUA says to measure hemoglobin and hematocrit before starting. While on therapy, a hematocrit of 54% or higher "warrants intervention," with dose adjustment as the first step when testosterone levels are high (AUA guideline). More on that in how high hematocrit becomes dangerous.

In 2025 the FDA required a warning about increased blood pressure on every testosterone product (FDA, 2025). Both labels now say testosterone "can increase blood pressure which can increase cardiovascular (CV) risk over time" and advise periodic checks. See whether TRT raises blood pressure.

The same FDA update removed the boxed-warning language about cardiovascular outcomes after the TRAVERSE trial. TRAVERSE (NEJM 2023) enrolled 5,246 men aged 45 to 80 with, or at high risk of, heart disease. Major cardiac events occurred in 7.0% on testosterone and 7.3% on placebo over about 3 years of follow-up, which met the trial's test for noninferiority (not worse than placebo). Atrial fibrillation, acute kidney injury, and pulmonary embolism were more common on testosterone (TRAVERSE). The trial used a daily gel, not enanthate or cypionate injections, and it shows safety for major events, not protection.

Who should not use either one?

The cypionate label rules it out for men with breast cancer, known or suspected prostate cancer, serious heart, liver, or kidney disease, or a known hypersensitivity to the drug. It says testosterone is not recommended with uncontrolled high blood pressure (DEPO-Testosterone label).

The AUA adds two more:

• Men trying to conceive: "Exogenous testosterone therapy should not be prescribed to men who are currently trying to conceive" (AUA guideline). The ester makes no difference here. Fertility and testosterone covers the options.
• Men whose hematocrit is above 50% before starting: testosterone should be withheld until the cause is explained (AUA guideline).

What labs apply to either ester?

The same ones. The AUA aims for total testosterone in the middle third of the normal range, 450 to 600 ng/dL for most labs, and says to measure testosterone every 6 to 12 months on therapy (AUA guideline). The AUA also calls for hematocrit before starting, and both labels call for periodic checks after that.

Common questions

Can I switch from one to the other? No trial has studied switching between them, and no guideline addresses it. The label dose ranges are the same, so a switch is your prescriber's call. When starting either one, the AUA table schedules a testosterone check after the fourth dosing cycle.

Which one is better for once-a-week shots? The AUA lists the same 7 to 14 day interval for both. Enanthate at 100 mg weekly has been studied directly (Snyder and Lawrence), and cypionate's label half-life is about 8 days. No study compares the two on a weekly schedule.

Will I feel different on one? No controlled study has tested whether men feel different on one ester than the other. In the enanthate study, changing the dose and schedule changed the average level between shots.

Bottom line

Enanthate and cypionate deliver the same hormone, carry the same label dose range and warnings, and need the same labs. The clearest differences are the oil and preservative in each vial. Published half-life numbers for enanthate vary and none comes from its label, so a claim that one ester gives a much smoother ride isn't backed by a head-to-head trial.

AlphaMD providers review your labs before prescribing either ester; see testosterone replacement therapy at AlphaMD.